Compare CRS & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRS | SNN |
|---|---|---|
| Founded | 1910 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.4B | 14.0B |
| IPO Year | N/A | 1999 |
| Metric | CRS | SNN |
|---|---|---|
| Price | $304.00 | $33.44 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $374.60 | $32.83 |
| AVG Volume (30 Days) | ★ 768.4K | 476.9K |
| Earning Date | 10-23-2025 | 03-02-2026 |
| Dividend Yield | 0.26% | ★ 2.19% |
| EPS Growth | ★ 82.03 | 59.91 |
| EPS | ★ 8.18 | 0.56 |
| Revenue | $2,893,200,000.00 | ★ $5,944,000,000.00 |
| Revenue This Year | $7.26 | $7.78 |
| Revenue Next Year | $8.98 | $5.13 |
| P/E Ratio | $37.56 | ★ $29.10 |
| Revenue Growth | 2.40 | ★ 5.35 |
| 52 Week Low | $138.61 | $23.69 |
| 52 Week High | $342.11 | $38.79 |
| Indicator | CRS | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 48.51 | 48.01 |
| Support Level | $306.53 | $32.68 |
| Resistance Level | $320.66 | $33.56 |
| Average True Range (ATR) | 12.49 | 0.41 |
| MACD | -3.49 | 0.14 |
| Stochastic Oscillator | 29.16 | 78.51 |
Carpenter Technology Corp supplies specialty metals to a variety of end markets, including aerospace and defense, industrial machinery and consumer durables, medical, and energy, among others. The company's reportable segments include; Specialty Alloys Operations and Performance Engineered Products. It generates maximum revenue from the Specialty Alloys Operations segment. The SAO segment is comprised of the company's alloy and stainless steel manufacturing operations. This includes operations performed at mills predominantly in Reading and Latrobe, Pennsylvania, and surrounding areas as well as South Carolina and Alabama. Geographically, the company derives its maximum revenue from the United States and the rest from Europe, Asia Pacific, Mexico, Canada, and other regions.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.